Data generated by the working group, which includes molecular profiling of over 10,000 tumors across 33 tumor types as well as a series of results on immune - tumor interaction and response mechanisms, will provide
rich characterizations of the relationship
between tumors and the immune microenvironment and its impact on patient outcomes.